Originally published online as doi:10.1189/jlb.0804459 on April 7, 2005
Published online before print April 7, 2005
(Journal of Leukocyte Biology. 2005;78:248-258.)
© 2005
by Society for Leukocyte Biology
Asymmetrical protein kinase A activity establishes neutrophil cytoskeletal polarity and enables chemotaxis
Samuel L. Jones1 and
Yousuf Sharief
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh
1 Correspondence: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St., Raleigh, NC 27606. E-mail: sam_jones{at}ncsu.edu
Neutrophil chemotaxis requires precise spatial organization of the actin cytoskeleton and integrin activation to polarize the cell and enable migration. Protein kinase A (PKA) activity regulates integrin activation and actin cytoskeletal organization, suggesting that PKA is a key element in the mechanism regulating neutrophil chemotaxis. Our hypothesis is that asymmetrical PKA activity is critical for establishing neutrophil adhesive and cytoskeletal polarity required for migration during chemotaxis. To test this hypothesis, we first determined that global treatment with the PKA inhibitor KT5720 decreased formylated Met-Leu-Phe (fMLF)-induced migration. The ability of PKA inhibitors to reduce migration correlated with increased overall ß2 integrin cell-surface expression, affinity activation, and cellular adhesion. We next determined whether asymmetrical PKA activity was sufficient to induce migration. Exposure to gradient of the PKA inhibitors KT5720 or H-89 or a stearated, cell-permeant peptide (St-Ht31), which inhibits PKA binding to anchorage proteins, stimulated neutrophil migration in a chemotaxis chamber. Global treatment with KT5720 abolished the ability of fMLF to polarize the neutrophil actin cytoskeleton. In contrast to global treatment with KT5720, a point source of KT5720 was sufficient to polarize the actin cytoskeleton. The ability of KT5720 and St-Ht31 to stimulate migration was abolished by pretreatment with the phosphatidylinositol-3 kinase (PI-3K) inhibitors wortmannin and LY294002. These data suggest that asymmetrical PKA activity is necessary and sufficient for actin cytoskeletal polarization and migration during neutrophil chemotaxis. In addition, our data suggest PI-3K is an effector of PKA during chemotaxis.
Key Words: integrin adhesion migration actin cytoskeleton phosphatidylinositol-3 kinase
This article has been cited by other articles:

|
 |

|
 |
 
J. Kamanova, O. Kofronova, J. Masin, H. Genth, J. Vojtova, I. Linhartova, O. Benada, I. Just, and P. Sebo
Adenylate Cyclase Toxin Subverts Phagocyte Function by RhoA Inhibition and Unproductive Ruffling
J. Immunol.,
October 15, 2008;
181(8):
5587 - 5597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Helmke
Choosing Sides in Polarized Endothelial Adaptation to Shear Stress
Circ. Res.,
July 18, 2008;
103(2):
122 - 124.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Chilcoat, Y. Sharief, and S. L. Jones
Tonic protein kinase A activity maintains inactive {beta}2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase
J. Leukoc. Biol.,
April 1, 2008;
83(4):
964 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Eckert and S. L. Jones
Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant
J. Leukoc. Biol.,
November 1, 2007;
82(5):
1311 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Lorenowicz, M. Fernandez-Borja, and P. L. Hordijk
cAMP Signaling in Leukocyte Transendothelial Migration
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1014 - 1022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zhao, P. Nalbant, M. Hoshino, X. Dong, D. Wu, and G. M. Bokoch
Signaling requirements for translocation of P-Rex1, a key Rac2 exchange factor involved in chemoattractant-stimulated human neutrophil function
J. Leukoc. Biol.,
April 1, 2007;
81(4):
1127 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the Society for Leukocyte Biology.